Immunogenicity and correlates of protection of COVID-19 vaccines in medical staff and special risk populations
Latest Information Update: 15 Sep 2023
At a glance
- Drugs Ad26.COV2 S (Primary) ; AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 12 Sep 2023 Planned number of patients changed from 2900 to 3050.
- 12 Feb 2022 Status changed from recruiting to completed.
- 05 Jul 2021 Planned number of patients changed from 2250 to 2900.